- Pyridoxine
- Pyridoxine dipalmitate
- Pyridoxine hydrochloride
- Pyridoxine phosphate
- Pyridoxine tripalmitate
- 65236-62-69H-Pyrido[3,4-b]indole, 1-ethenyl-4,8-dimethoxy-
- 652-36-81,4-Benzenedicarboxylicacid, 2,3,5,6-tetrafluoro-
- 652-37-97H-Purine-7-aceticacid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-
- 652-39-13-Fluorophthalic anhydride
- 652-40-41,3-Isobenzofurandione,4,7-difluoro-
- 65243-33-65-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-,(2,2-dimethyl-1-oxopropoxy)methyl ester, (6R,7R)-
- 652-46-0Phenol,4-[bis[4-(dimethylamino)phenyl]methyl]-
- 65253-04-5Cyclohexanol,5-methyl-2-(1-methyl-1-phenylethyl)-, (1R,2S,5R)-
- 65253-54-51H-Imidazolium, 1-ethenyl-1-methyl-, methyl sulfate, polymer with ethenylbenzene and 2-methylpropyl 2-propenoate
- 65256-47-5Fotofil (9CI)
Hot Products
- 143527-70-23,5-Oxazolidinedicarboxylicacid, 2,2-dimethyl-4-phenyl-, 3-(1,1-dimethylethyl) ester, (4S,5R)-
- 74103-06-3Ketorolac
- 11115-82-5Enduracidin
- 7012-16-02,7-Dichlorofluorene
- 853029-57-91H-Purine-2,6-dione,8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
- 6217-54-54,7,10,13,16,19-Docosahexaenoicacid, (4Z,7Z,10Z,13Z,16Z,19Z)-
- 17341-93-4Carbonochloridicacid, 2,2,2-trichloroethyl ester
- 140-89-6Carbonodithioic acid, O-ethyl ester, potassium salt (1:1)
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Pyridoxine |
EINECS | 200-603-0 |
| CAS No. | 65-23-6 | Density | 1.353 g/cm3 |
| PSA | 73.58000 | LogP | 0.08020 |
| Solubility | 0.1 g/mL at 20 °C in water, clear, colorless | Melting Point |
214-215 °C(lit.) |
| Formula | C8H11NO3 | Boiling Point | 491.9 °C at 760 mmHg |
| Molecular Weight | 169.18 | Flash Point | 251.3 °C |
| Transport Information | N/A | Appearance | crystalline solid |
| Safety | 26-36 | Risk Codes | 36/37/38 |
| Molecular Structure |
|
Hazard Symbols |
 Xi
|
| Synonyms |
Pyridoxol(8CI);2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine;2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine;5-Hydroxy-6-methyl-3,4-pyridinedimethanol;Adermin;Bezatin;Pirivitol;Pyridoxin;VB6; |
Article Data | 71 |
Pyridoxine Chemical Properties
.jpg)
IUPAC Name: 4,5-bis(Hydroxymethyl)-2-methylpyridin-3-ol
Molecular Formula: C8H11NO3
Molecular Weight: 169.177840 g/mol
EINECS: 200-603-0
Classification Code: Drug / Therapeutic Agent; Growth Substances; Human Data; Micronutrients; Vitamin B Complex; Vitamins
Melting Point: 214-215 °C(lit.)
storage temp.: 2-8 °C
solubility: H2O: 0.1 g/mL at 20 °C, clear, colorless
Stability: Stable. Incompatible with strong oxidizing agents.
Index of Refraction: 1.62
Molar Refractivity: 43.95 cm3
Molar Volume: 124.9 cm3
Surface Tension: 69.7 dyne/cm
Density: 1.353 g/cm3
Flash Point: 251.3 °C
Enthalpy of Vaporization: 79.91 kJ/mol
Boiling Point: 491.9 °C at 760 mmHg
Vapour Pressure of Pyridoxine (CAS NO.65-23-6): 1.71E-10 mmHg at 25 °C
Pyridoxine Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| man | TDLo | oral | 5143mg/kg/17W (5143mg/kg) | PERIPHERAL NERVE AND SENSATION: LOCAL ANESTHETIC | New England Journal of Medicine. Vol. 309, Pg. 445, 1983. |
| mouse | LD50 | intraperitoneal | 966mg/kg (966mg/kg) | Farmakologiya i Toksikologiya Vol. 40, Pg. 371, 1977. | |
| mouse | LD50 | intravenous | 545mg/kg (545mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 683, 1960. | |
| rat | LD50 | intraperitoneal | 1500mg/kg (1500mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Proceedings of the European Society for the Study of Drug Toxicity. Vol. 4, Pg. 179, 1964. |
| rat | LD50 | intravenous | 657mg/kg (657mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Proceedings of the Society for Experimental Biology and Medicine. Vol. 44, Pg. 147, 1940. |
| rat | LD50 | oral | 4gm/kg (4000mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Proceedings of the Society for Experimental Biology and Medicine. Vol. 43, Pg. 116, 1940. |
| rat | LD50 | subcutaneous | 3100mg/kg (3100mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Proceedings of the Society for Experimental Biology and Medicine. Vol. 43, Pg. 116, 1940. |
| women | TDLo | oral | 139mg/kg/5Y-I (139mg/kg) | PERIPHERAL NERVE AND SENSATION: PARESTHESIS | New England Journal of Medicine. Vol. 311, Pg. 986, 1984. |
| women | TDLo | oral | 2100mg/kg/30D (2100mg/kg) | PERIPHERAL NERVE AND SENSATION: PARESTHESIS BEHAVIORAL: ATAXIA | Neurology. Vol. 35, Pg. 1466, 1985. |
| women | TDLo | oral | 4800mg/kg/17W (4800mg/kg) | PERIPHERAL NERVE AND SENSATION: LOCAL ANESTHETIC | New England Journal of Medicine. Vol. 309, Pg. 445, 1983. |
Pyridoxine Consensus Reports
Reported in EPA TSCA Inventory.
Pyridoxine Safety Profile
Moderately toxic by ingestion, subcutaneous, intravenous, and intraperitoneal routes. Human systemic effects: ataxia, local anesthetic, paresthesia. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes: 
Xi
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
WGK Germany: 3
RTECS of Pyridoxine (CAS NO.65-23-6): UV1350000
Pyridoxine Specification
Pyridoxine (CAS NO.65-23-6), its Synonyms are 3,4-Pyridinedimethanol, 5-hydroxy-6-methyl- ; 5-Hydroxy-6-methyl-3,4-pyridinedimethanol ; 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine ; 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine ; 2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin ; Adermine . It is crystalline solid.
What can I do for you?
Get Best Price
